GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChromaDex Corp (FRA:OCD1) » Definitions » Short Percentage of Float

ChromaDex (FRA:OCD1) Short Percentage of Float


View and export this data going back to 2016. Start your Free Trial

What is ChromaDex Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of ChromaDex's Short Percentage of Float

For the Biotechnology subindustry, ChromaDex's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ChromaDex's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ChromaDex's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where ChromaDex's Short Percentage of Float falls into.


ChromaDex (FRA:OCD1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChromaDex Corp (FRA:OCD1) » Definitions » Short Percentage of Float
Comparable Companies
ANIX NKTX INO PRLD IFRX VXRT THRX PRQR MNOV AADI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
CDXC:USA
Address
10900 Wilshire Boulevard, Suite 600, Los Angeles, CA, USA, 90024
Website
https://www.chromadex.com
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segment namely Consumer Products, Ingredients segment and Analytical Reference Standards and Services. Majority of the revenue is earned from Consumer Products segment.

ChromaDex (FRA:OCD1) Headlines

No Headlines